Cours Cantabio Pharmaceuticals Inc. Other OTC
Actions
CTBO
US13808X2036
Recherche biotechnologique et médicale
CA 2017 | - | CA 2018 | - | Capitalisation | 2,36 M 2,14 M |
---|---|---|---|---|---|
Résultat net 2017 | -1 M -908 k | Résultat net 2018 | -2 M -1,82 M | VE / CA 2017 | - |
Dette nette 2017 | 337 k 306 k | Dette nette 2018 | 1,1 M 995 k | VE / CA 2018 | - |
PER 2017 * |
-
| PER 2018 |
-
| Employés | - |
Rendement 2017 * |
-
| Rendement 2018 |
-
| Flottant | 29,99% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06/02/12 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/05/15 |
Max Zhu
BRD | Director/Board Member | 42 | 01/01/15 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/05/15 |
Gergely Tóth
FOU | Founder | 51 | 06/02/12 |
Max Zhu
BRD | Director/Board Member | 42 | 01/01/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,37% | 48,16 Md | |
-1,01% | 41,73 Md | |
+42,44% | 41,03 Md | |
-5,31% | 28,77 Md | |
+9,34% | 25,59 Md | |
-21,69% | 18,96 Md | |
+6,23% | 12,92 Md | |
+26,99% | 12,03 Md | |
-3,38% | 11,77 Md |